BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29402393)

  • 1. Acute Generalized Exanthematous Pustulosis Simulating Toxic Epidermal Necrolysis: Overlapping Processes.
    García Abellán J; Matarredona Catalá J; Jaen Larrieu A; Valencia Ramírez I
    Actas Dermosifiliogr (Engl Ed); 2018 Jun; 109(5):460-462. PubMed ID: 29402393
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe Cutaneous Drug Reactions: Do Overlapping Forms Exist?
    Horcajada-Reales C; Pulido-Pérez A; Suárez-Fernández R
    Actas Dermosifiliogr; 2016; 107(1):23-33. PubMed ID: 26520037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute generalized exanthematous pustulosis mimicking toxic epidermal necrolysis in patients with psoriasis.
    Smith VM; Pollock B; Wilkinson SM; Rose RF
    Clin Exp Dermatol; 2016 Jul; 41(5):561-2. PubMed ID: 26931079
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute generalized exanthematous pustulosis overlapping with toxic epidermal necrolysis successfully treated with etanercept.
    Ridha Z; Guirguis J; Ouchene L; Chergui M; Litvinov IV; Netchiporouk E
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e894-e896. PubMed ID: 34310752
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe acute generalized exanthematous pustulosis with blistering mimicking toxic epidermal necrolysis, associated with a primary mumps infection.
    Azib S; Florin V; Fourrier F; Delaporte E; Staumont-Sallé D
    Clin Exp Dermatol; 2014 Aug; 39(6):723-5. PubMed ID: 24986490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapidly progressive and fatal case of atypical acute generalized exanthematous pustulosis.
    Krishna S; Ortega-Loayza A; Malakouti N; Brinster N
    J Am Acad Dermatol; 2014 Sep; 71(3):e89-90. PubMed ID: 25128141
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
    Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
    J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature.
    Peermohamed S; Haber RM
    Arch Dermatol; 2011 Jun; 147(6):697-701. PubMed ID: 21690532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The major SCAR syndromes].
    Piérard GE; Lesuisse M; Piérard-Franchimont C
    Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute generalized exanthematous pustulosis mimicking toxic epidermal necrolysis in patients with psoriasis: a coincidence?
    Worsnop F; Chong H; Ostlere L; Natkunarajah J
    Clin Exp Dermatol; 2015 Aug; 40(6):688-9. PubMed ID: 25677856
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatments for Severe Cutaneous Adverse Reactions.
    Cho YT; Chu CY
    J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute generalized exanthematous pustulosis with overlap features of toxic epidermal necrolysis/Stevens-Johnson syndrome.
    Moling O; Perino F; Piccin A
    Int J Dermatol; 2014 Jan; 53(1):e27-8. PubMed ID: 23452000
    [No Abstract]   [Full Text] [Related]  

  • 14. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
    Owen CE; Jones JM
    Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute generalized exanthematous pustulosis with features mimicking toxic epidermal necrolysis secondary to amiodarone.
    Distel C; Bollea Garlatti ML; Torre AC; Riganti J
    An Bras Dermatol; 2020; 95(4):540-542. PubMed ID: 32522449
    [No Abstract]   [Full Text] [Related]  

  • 16. Deadly drug rashes: Early recognition and multidisciplinary care.
    Jaroenpuntaruk V; Gray A
    Cleve Clin J Med; 2023 Jun; 90(6):373-381. PubMed ID: 37263663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe cutaneous adverse reactions to drugs.
    Duong TA; Valeyrie-Allanore L; Wolkenstein P; Chosidow O
    Lancet; 2017 Oct; 390(10106):1996-2011. PubMed ID: 28476287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute generalized exanthematous pustulosis resembling toxic epidermal necrolysis caused by famotidine.
    Scheinfeld N; Wesson K; Perry P; Weinberg J
    Acta Derm Venereol; 2003; 83(1):76-7. PubMed ID: 12636039
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.
    Schwartz RA; McDonough PH; Lee BW
    J Am Acad Dermatol; 2013 Aug; 69(2):187.e1-16; quiz 203-4. PubMed ID: 23866879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin signs of severe systemic medication reactions.
    Treat JR
    Curr Probl Pediatr Adolesc Health Care; 2012 Sep; 42(8):193-7. PubMed ID: 22884025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.